PBC Landscape - Clinical Trials, Revenue Forecasts

Half The Pipeline From APAC Firms

Primary biliary cholangitis or cirrhosis, PBC, is a lesser-known cousin of MASH but a silent killer, nevertheless. Scrip studies data from Citeline’s Pharmaprojects and separately Evaluate Pharma to reveal a promising pipeline and drug revenue forecasts, with APAC firms accounting for half the pipeline of drugs

Human Liver Model

Liver or hepatic disease causes one out of 25 deaths worldwide, with nearly two-thirds of liver-related deaths in men and one-thirds in women.

More from Clinical Trials

More from Rare Diseases